Grünenthal is an API and finished-dose manufacturer based in Germany. It holds 2 valid CEPs across a filed portfolio of 2 molecules. Its filings concentrate with AIFA (IT), INFARMED (PT) and EMA. Its GMP standing is certified by ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| Aachen, United Arab Emirates | Not on file |
| AACHEN, Germany | Not on file |
| Aachen, Germany | Not on file |
| SAN BORJA, Peru | Not on file |
| SAN BORJA, Peru | Not on file |
| SAN BORJA, Peru | Not on file |
5 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Betahistine Dihydrochloride | EDQM | 1 |
| Tapentadol | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 724 | None |
| INFARMED (PT) | 146 | None |
| EMA | 104 | None |
| MHRA (UK) | 102 | None |
| MPA (SE) | 91 | None |
| FAMHP (BE) | 76 | None |
| ANVISA (Brazil) | None | 4 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Grünenthal comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.